Incannex Healthcare targeting clinical trial for sleep apnoea treatment following milestone FDA meeting

Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL), which specialises in medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies, has...

Related Keywords

United States ,Georgia ,Texas ,John Douglas Hudson ,Russell Rosenberg ,Nasdaq ,Incannex Healthcare Ltd ,Ohio State University ,Neurotrials Research In Atlanta ,Drug Administration ,Investigational New Drug ,Apneoa Hypopnea Index ,Sleep Medicine ,Principal Investigator ,Futuresearch Trials ,Chief Science Officer ,Neurotrials Research ,Ohio State ,